NEW YORK (Reuters) - Biopharmaceutical company Halozyme Therapeutics Inc on Sunday said Baxter International Inc has had "manufacturing failures" in making Hylenex, a fluid absorption drug Baxter licensed from Halozyme.
Comment on Halozyme: Baxter made manufacturing errors on drug
Reuters: U.S., Reuters: Nation
Sun, 05/16/2010 - 8:15pm
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more